dc.contributor.author
Gül-Klein, Safak
dc.contributor.author
Öllinger, Robert
dc.contributor.author
Schmelzle, Moritz
dc.contributor.author
Pratschke, Johann
dc.contributor.author
Schöning, Wenzel
dc.date.accessioned
2021-11-04T12:30:24Z
dc.date.available
2021-11-04T12:30:24Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/32540
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-32264
dc.description.abstract
Background and Objectives: Progressive familial intrahepatic cholestasis (PFIC) is a rare autosomal recessive inherited disease divided into five types (PFIC 1-5). Characteristic for all types is early disease onset, which may result clinically in portal hypertension, fibrosis, cirrhosis, hepatocellular carcinoma (HCC), and extrahepatic manifestations. Liver transplantation (LT) is the only successful treatment approach. Our aim is to present the good long-term outcomes after liver transplantation for PFIC1, focusing on liver function as well as the occurrence of extrahepatic manifestation after liver transplantation. Materials and Methods: A total of seven pediatric patients with PFIC1 underwent liver transplantation between January 1999 and September 2019 at the Department of Surgery, Charite Campus Virchow Klinikum and Charite Campus Mitte of Charite-Universitatsmedizin Berlin. Long-term follow-up data were collected on all patients, specifically considering liver function and extrahepatic manifestations. Results: Seven (3.2%) recipients were found from a cohort of 219 pediatric patients. Two of the seven patients had multilocular HCC in cirrhosis. Disease recurrence or graft loss did not occur in any patient. Two patients (male, siblings) had persistently elevated liver parameters but showed excellent liver function. Patient and graft survival during long-term follow-up was 100%, and no severe extrahepatic manifestations requiring hospitalization or surgery occurred. We noted a low complication rate during long-term follow-up and excellent patient outcome. Conclusions: PFIC1 long-term follow-up after LT shows promising results for this rare disease. In particular, the clinical relevance of extrahepatic manifestations seems acceptable, and graft function seems to be barely affected. Further multicenter studies are needed to analyze the clinically inhomogeneous presentation and to better understand the courses after LT.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
liver transplantation
en
dc.subject
progressive familial intrahepatic cholestasis
en
dc.subject
long-term outcome
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Long-Term Outcome after Liver Transplantation for Progressive Familial Intrahepatic Cholestasis
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
854
dcterms.bibliographicCitation.doi
10.3390/medicina57080854
dcterms.bibliographicCitation.journaltitle
Medicina
dcterms.bibliographicCitation.number
8
dcterms.bibliographicCitation.originalpublishername
MDPI AG
dcterms.bibliographicCitation.volume
57
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
34441060
dcterms.isPartOf.eissn
1648-9144